Prediction of Anti-VEGF Response in Diabetic Macular Edema After 1 Injection.

Shah, Ankoor R; Yonekawa, Yoshihiro; Todorich, Bozho; Van Laere, Lily; Hussain, Rehan; Woodward, Maria A; Abbey, Ashkan M; Wolfe, Jeremy D

Shah, Ankoor R; Yonekawa, Yoshihiro; Todorich, Bozho; Van Laere, Lily; Hussain, Rehan; Woodward, Maria A; Abbey, Ashkan M; Wolfe, Jeremy D.

Afiliação

Shah AR; Retina Consultants of Houston, Houston, TX.
Yonekawa Y; Department of Ophthalmology, Blanton Eye Institute, The Methodist Hospital, Houston, TX.
Todorich B; Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Beaumont Eye Institute, Royal Oak, MI.
Van Laere L; Associated Retinal Consultants, Royal Oak, MI.
Hussain R; Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Beaumont Eye Institute, Royal Oak, MI.
Woodward MA; Associated Retinal Consultants, Royal Oak, MI.
Abbey AM; Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Beaumont Eye Institute, Royal Oak, MI.
Wolfe JD; Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN.

J Vitreoretin Dis ; 1(3): 169-174, 2017 May.

Article em En | MEDLINE | ID: mdl-29104958

Palavras-chave

Anti-VEGF; Diabetic Macular Edema; Diabetic Retinopathy; Receiver Operating Characteristics Curve; Vascular Endothelial Growth Factor

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Vitreoretin Dis Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google